share_log

BioCryst Pharmaceuticals | 8-K: BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones

SEC announcement ·  Feb 26 07:10
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more